US 10874633
Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity
granted A61KA61K31/136A61K31/352
Quick answer
US patent 10874633 (Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity) held by Auransa Inc. expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Auransa Inc.
- Grant date
- Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/136, A61K31/352, A61K31/353, A61K31/404